Skip to main content

Table 3 Univariate analysis of patient characteristics between the postanesthetic shivering (PAS) group and non-postanesthetic shivering (non-PAS) group

From: Efficacy of flurbiprofen axetil for preventing postanesthetic shivering in patients undergoing gynecologic laparotomy surgeries

  PAS group (n = 30) Non-PAS group (n = 111) p value
Age (year) 41 ± 9 (24-67) 51 ± 13 (21-84) < 0.001
Body mass index (kg/m2) 23.3 ± 3.9 (17.4-36.0) 23.8 ± 5.0 (16.0-46.1) 0.774
Co-morbidities
 Hypertension 4 (13.3) 22 (19.8) 0.416
 Diabetes mellitus 1 (3.3) 7 (6.3) 0.532
 Bronchial asthma 4 (3.3) 15 (13.5) 0.195
Malignancy 13 (43.3) 57 (51.3) 0.976
Operation time (min) 166 ± 75 (75-356) 137 ± 49 (47-319) 0.096
Anesthesia time (min) 233 ± 92 (114-458) 198 ± 54 (103-381) 0.103
Blood loss (g) 723 ± 837 (10-3519) 376 ± 418 (5-2316) 0.093
Fluid infusion (ml/kg/h) 8.8 ± 2.9 (3.6-14.2) 9.0 ± 3.2 (3.4-16.7) 0.924
Fentanyl dosage (μg/kg) 4.2 ± 1.8 (1.6-9.8) 4.7 ± 1.7 (0.9-10.9) 0.273
Remifentanil dosage (mg) 2.4 ± 1.2 (0.8-6.0) 1.8 ± 0.8 (0.8-6.0) 0.015
Body temperature (°C)
 Highest body temperature 36.8 ± 0.3 (36.3-37.4) 36.8 ± 0.4 (35.8-38.0) 0.635
 Lowest body temperature 36.2 ± 0.5 (35.1-37.0) 36.3 ± 0.4 (35.1-37.3) 0.549
Epidural analgesia 29 (96.7) 98 (88.3) 0.173
Flurbiprofen axetil 2 (6.7) 29 (26.1) 0.022
  1. PAS postanesthetic shivering
  2. The data are given as patient’s number (%) or the mean ± standard deviation (range)